Network Dashboard
Multi-site portfolio performance and optimization
ACTIVE TRIALS
6
4G / 1A / 1R
Across 4 sites
ENROLLMENT
57%
799 / 1,390 patients
BUDGET
57%
+3% INF$16.7M / $28.7M
CRITICAL RISKS
5
Require immediate attention
AVG ENROLLMENT RATE
24.5
patients/month
TOTAL FTE
28.5 / 30
95% utilized
ACTIVE SITES
4
4 with active trials
TOTAL PORTFOLIO VALUE
$28.7M
Across 6 active protocols
Active Trials
APEX-301
PHASE III
Advanced Non-Small Cell Lung Cancer
Apex Therapeutics • Oncology
ENROLLMENT
287 / 450
64%
BUDGET
$5.1M
60% of $8.5M
SCREEN FAILURES
12.8%
vs 15.0% benchmark
4 sites: Nashville, Memphis, Knoxville, Chattanooga
CARDIO-SHIELD-2
PHASE II
Heart Failure with Reduced Ejection Fraction
HeartBio Sciences • Cardiology
ENROLLMENT
142 / 200
71%
BUDGET
$2.5M
60% of $4.2M
SCREEN FAILURES
16.5%
vs 18.0% benchmark
2 sites: Nashville, Memphis
NEURO-PATH-7
PHASE III
Alzheimer's Disease
NeuroScience Corp • Neurology
ENROLLMENT
156 / 350
45%
BUDGET
$3.5M
50% of $7.0M
SCREEN FAILURES
30.4%
vs 25.0% benchmark
3 sites: Nashville, Knoxville, Memphis
METABOFIX-1
PHASE II
Type 2 Diabetes Mellitus
Endocrine Solutions Inc • Endocrinology
ENROLLMENT
124 / 180
69%
BUDGET
$2.2M
60% of $3.6M
SCREEN FAILURES
12.7%
vs 15.0% benchmark
2 sites: Memphis, Chattanooga
RESPI-CLEAR-4
PHASE II
Chronic Obstructive Pulmonary Disease
PulmoTech Pharmaceuticals • Pulmonology
ENROLLMENT
52 / 150
35%
BUDGET
$1.5M
50% of $3.0M
SCREEN FAILURES
46.4%
vs 20.0% benchmark
1 sites: Knoxville
ONCO-BRIDGE-9
PHASE I
Advanced Solid Tumors
Bridgeway Oncology • Oncology
ENROLLMENT
38 / 60
63%
BUDGET
$1.4M
60% of $2.4M
SCREEN FAILURES
17.4%
vs 20.0% benchmark
2 sites: Nashville, Chattanooga
CRITICAL RISKS
20
Screen failure rate significantly above benchmark
ENROLLMENT • Dr. Sarah Chen
16
Budget overrun due to extended enrollment period
BUDGET • Finance Team
25
Extremely high screen failure rate due to restrictive spirometry criteria
ENROLLMENT • Dr. Emily Rodriguez
20
Study may not complete on time or budget
BUDGET • Finance Team
16
Single site creates enrollment bottleneck
OPERATIONAL • Dr. Emily Rodriguez
RESOURCE UTILIZATION
Nashville
12 / 12 FTE
100% utilized
Memphis
8 / 8 FTE
100% utilized
Knoxville
4.5 / 6 FTE
75% utilized
Chattanooga
4 / 4 FTE
100% utilized
RECENT ACTIVITY
Patient APX-287 enrolled successfully
3/18/2025, 2:23:00 PM
Screen failure rate exceeded 30% threshold - Risk escalated to CRITICAL
3/18/2025, 11:15:00 AM
Budget utilization reached 60% - On track with projections
3/18/2025, 9:45:00 AM
Cohort 3 enrollment milestone completed ahead of schedule
3/17/2025, 4:30:00 PM
Patient MBF-124 enrolled successfully
3/17/2025, 2:20:00 PM
Protocol Amendment 3.2 submitted to IRB for review
3/17/2025, 10:00:00 AM